Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

27.94
-0.1500-0.53%
Pre-market: 27.67-0.2700-0.97%06:06 EST
Volume:3.19M
Turnover:88.37M
Market Cap:3.14B
PE:-27.70
High:28.30
Open:28.18
Low:26.97
Close:28.09
Loading ...

Stock Track | Viking Therapeutics Plunges Over 9% in Pre-Market After Q4 Earnings Miss, Lack of Major Pipeline Updates

Stock Track
·
06 Feb

Viking Therapeutics Inc (VKTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...

GuruFocus.com
·
06 Feb

24H|Skyworks Solutions Sinks 22%; AMSC Soars 13%; BigBear.ai up 5% After Soaring 45% Wednesday

Tiger Newspress
·
06 Feb

Viking Therapeutics Plummeted 10% On Its Earnings Report. Here's Why.

Blockhead
·
06 Feb

Stock Track | Viking Therapeutics Plunges 10% Despite Positive Pipeline Updates on Obesity and NASH Drugs

Stock Track
·
06 Feb

Viking Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Feb

Viking Therapeutics Shares Drop After Q4 EPS Miss Estimates

Benzinga
·
06 Feb

Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers

Insider Monkey
·
06 Feb

Stock Track | Viking Therapeutics Plunges 6.75% After-Hours Despite Positive Q4 Results and Clinical Pipeline Updates

Stock Track
·
06 Feb

Viking Therapeutics reports Q4 EPS (32c), consensus (27c)

TIPRANKS
·
06 Feb

Viking Therapeutics Q4 2024 GAAP EPS $(0.32) Misses $(0.28) Estimate

Benzinga
·
06 Feb

Viking Therapeutics Q4 Income From Operations USD -46.238 Million VS. Ibes Estimate USD -38.5 Million

THOMSON REUTERS
·
06 Feb

Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

PR Newswire
·
06 Feb

Viking Therapeutics options imply 8.9% move in share price post-earnings

TIPRANKS
·
06 Feb

Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics?

Insider Monkey
·
04 Feb

Jim Cramer’s Take on Viking Therapeutics (VKTX): “Sell Viking Therapeutics and Roll it into Viking Holdings”

Insider Monkey
·
02 Feb